Stratification of patients from our HNSCC cohort, using TBC1D14 expression, confirmed similar clinical outcome and poor OS of TBC1D14 low expression patients, comparable with the TCGA cohort (Fig. 2G). Here, TBC1D14 is linked to head and neck squamous cell carcinoma.